Free Trial

Provectus Biopharmaceuticals (PVCT) SEC Filings & 10K Form

Provectus Biopharmaceuticals logo
$0.08 +0.00 (+3.45%)
As of 07/25/2025 03:48 PM Eastern

Recent Provectus Biopharmaceuticals SEC Filings

DateFilerForm TypeView
07/21/2025
11:03 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
11:36 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/23/2025
1:47 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2025
5:15 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2025
7:42 AM
Provectus Biopharmaceuticals (Filer)
Form DEFA14A
06/18/2025
7:43 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2025
5:24 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/27/2025
3:32 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
1:24 PM
Provectus Biopharmaceuticals (Filer)
Form 10-K/A
05/15/2025
8:09 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
8:46 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
5:14 AM
Provectus Biopharmaceuticals (Filer)
Form ARS
04/30/2025
10:38 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
1:22 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
12:35 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
2:13 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
4:06 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
6:20 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
7:37 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
10:47 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:26 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
10:10 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
12:37 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
4:13 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
2:57 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
12:31 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:33 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
8:30 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
8:00 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
6:45 PM
Pershing Edward (Filed by)
Provectus Biopharmaceuticals (Subject)
Form SC 13D/A
12/02/2024
6:48 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:12 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
7:00 AM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
11:31 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
6:58 PM
Bailey Webster (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:01 PM
Lacey John III (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:06 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:56 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
5:58 PM
Provectus Biopharmaceuticals (Issuer)
Rodrigues Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
4:21 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
8:54 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Critical AI announcement set to ignite AI 2.0 (Ad)

I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring.

Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave.
08/27/2024
10:15 AM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
2:06 PM
Provectus Biopharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2024
6:23 PM
Morris Jeffrey Allen (Filed by)
Provectus Biopharmaceuticals (Subject)
Form SC 13G
08/14/2024
6:19 PM
Morris Jeffrey Allen (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
12:21 PM
Provectus Biopharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
2:31 PM
Pershing Edward (Reporting)
Provectus Biopharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (OTCMKTS:PVCT) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners